Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2018/08/015263
CTRI/2018/08/015263CompletedUnknown

"efficacy of omega 3 fatty acid as an adjunct in managing chronic moderate periodontitis compared to subgingival scaling and root planning ";a randomized controlled trial

Dr shirish kumar kujur1 site in 1 country110 target enrollmentStarted: July 14, 2014Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Unknown
Status
Completed
Sponsor
Enrollment
110
Locations
1
Primary Endpoint
outcome is the reduction in pocket depth upto 1mm in 3 month
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Patients with chronic moderate periodontitis having probing pocket depth (3 -5mm) will be taken for study. They will be randomly allocated into two groups, case  and control  group.. scaling and root planning followed by medication (omega 3 fatty acid for 1 month) will be given to the patients of   case group and control group will be provided scaling and root planning only. follow up will be done at 1 and 4 month to check periodontal measurements.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Participant Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •patients with chronic moderate periodontitis having probing pocket depth (3.

Exclusion Criteria

  • •1.pregnancy and lactation 2.history of any drug intake.

Outcomes

Primary Outcomes

outcome is the reduction in pocket depth upto 1mm in 3 month

Time Frame: outcome is the reduction in pocket depth upto 1mm in 3 month

Secondary Outcomes

  • n/a(n/a)

Investigators

Sponsor
Dr shirish kumar kujur
Sponsor Class
Other [self sponsor]

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Not Applicable
Benefits of systemically administered omega 3 fatty acids on nuclear factor kappa b levels in patients with rheumatoid arthritis and periodontitis .Chronic periodontitis, (2) ICD-10 Condition: M057||Rheumatoid arthritis with rheumatoid factor without organ or systems involvement,
CTRI/2023/04/051411Panineeya Institute of Dental Sciences and Research centre24
Completed
Phase 2
Effect of Omega 3 on Periodontitis in Postmenopausal WomenChronic Periodontitis
NCT02764879October 6 University50
Completed
Not Applicable
Omega-3 Polyunsaturated Fatty Acids in Non-surgical Treatment of PeriodontitisTherapeuticsFatty Acids, UnsaturatedPeriodontitis
NCT04477395Medical University of Lodz50
Completed
Not Applicable
Clinical Assessment of Adjunctive Omega-3 Versus Vitamin D Daily Supplements on Active Periodontal Therapy With Stage II Grade B Periodontitis PatientsVitamin D Deficiency
NCT06654063Cairo University72
Unknown
Phase 2
Omega-3 and Quality of Life in Recurrent Aphthous Stomatitis PatientsRecurrent Mouth Ulcers
NCT01831453October 6 University50